Gold-catalyzed meyer-schuster rearrangement: Application to the synthesis of prostaglandins

Organometallics

Volumn 29, Issue 16, 2010, Pages 3665-3668

  Ramón, Rubén S ^a   Gaillard, Sylvain ^a   Slawin, Alexandra M Z ^a   Porta, Alessio ^b   D'Alfonso, Alessandro ^b   Zanoni, Giuseppe ^b   Nolan, Steven P ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GOLD CATALYSTS; MEYER-SCHUSTER REARRANGEMENT; SYNTHETIC APPROACH; SYNTHETIC PATHWAYS;

GOLD;

EID: 77955683408     PISSN: 02767333     EISSN: 15206041     Source Type: Journal    
DOI: 10.1021/om1005534     Document Type: Article

References (19)

1. For a recent review on the Meyer-Schuster rearrangement, see: Cadierno, V.; Crochet, P.; García-Garrido, S. E.; Gimeno, J. Dalton Trans. 2010, 39, 4015-4031. See also references cited therein.
2. Ramón, R. S.; Marion, N.; Nolan, S. P. Tetrahedron 2009, 65, 1767-1773
3. Gaillard, S.; Slawin, A. M. Z.; Nolan, S. P. Chem. Commun. 2010, 46, 2742-2744
4. Gaillard, S.; Bosson, J.; Ramón, R. S.; Nun, P.; Nolan, S. P. Manuscript submitted.
5. Ricard, L.; Gagosz, F. Organometallics 2007, 26, 4704-4707
6. 2 ligand in gold complexes, see: Weber, D.; Tarselli, M. A.; Gagné, M. R. Angew. Chem., Int. Ed. 2009, 48, 5733-5736
7. CCDC 772704 (4) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallograophic Data Centre via www.ccdc.cam.ac.uk/data-request/cif.
8. Of note, the use of a co-catalyst performing chloride abstraction in gold catalysts is not strictly required for some catalytic systems: For an example, see: Sromek, A. W.; Rubina, M.; Gevorgyan, V. J. Am. Chem. Soc. 2005, 127, 10500-10501
9. For previous examples of gold catalyst acid activation, see: Teles, J. H.; Brode, S.; Chabanas, M. Angew. Chem., Int. Ed. 1998, 37, 1415-1418
10. Mizushima, E.; Sato, K.; Hayashi, T.; Tanaka, M. Angew. Chem., Int. Ed. 2002, 41, 4563-4565
11. Hoffmann-Röder, A.; Krause, N. Angew. Chem., Int. Ed. 2004, 43, 1196-1216
12. Miller, S. B. Semin. Arthritis Rheum. 2006, 36, 37-49
13. Smyth, E. M.; Burke, A.; FitzGerald, G. A. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11 th ed.; Brunton, L. L., Ed.; McGraw-Hill Medical Publishing Division, 2005; pp 653-667.
14. 2α, see: Corey, E. J.; Noyori, R. Tetrahedron Lett. 1970, 11, 311-313
15. Trost, B. M. Science 1991, 254, 1471-1477
16. Trost, B. M. Angew. Chem., Int. Ed. Engl. 1995, 34, 259-281
17. Brown, H. C.; Ramachandran, P. V. Acc. Chem. Res. 1992, 25, 16-24
18. Sheddan, N. A.; Mulzer, J. Org. Lett. 2006, 8, 3101-3104
19. Dinuclear intermediates in gold catalysis have been proposed: Cheong, P. H.-Y.; Morganelli, P.; Luzung, M. R.; Houk, K. N.; Toste, F. D. J. Am. Chem. Soc. 2008, 130, 4517-4526